home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

49 rows where docket_id = "FDA-1975-N-0012" and posted_year = 2015 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

document_type 2

  • Supporting & Related Material 35
  • Other 14

posted_year 1

  • 2015 · 49 ✖

agency_id 1

  • FDA 49
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1975-N-0012-0636 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Supplement from American Cleaning Institue (ACI) Other Supplement (SUP) 2015-11-20T05:00:00Z 2015 11 2015-11-20T05:00:00Z   2016-03-10T21:51:30Z   0 0 0900006481d5fde2
FDA-1975-N-0012-0634 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Memorandum of Meeting Minutes from FDA CDER to Lonza America, Inc. Other Minutes 2015-10-23T04:00:00Z 2015 10 2015-10-23T04:00:00Z   2015-10-23T15:08:58Z   0 0 0900006481ce5bc0
FDA-1975-N-0012-0635 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Advice Letter from FDA CDER to Lewis & Harrison Other Letter(s) 2015-10-23T04:00:00Z 2015 10 2015-10-23T04:00:00Z   2015-10-23T15:12:31Z   0 0 0900006481ce5bc1
FDA-1975-N-0012-0630 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 8 Volume 2 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:16:48Z   0 0 09000064818c25ed
FDA-1975-N-0012-0622 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 1 Neeper Bradley, T.L. and Kubena, M.F. Developmental Toxicity Evaluation of ADBAC Administered by Gavage to New Zealand Rabbits re Comment from the ADBAC Steering Committee Lewis & Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:14:11Z   0 0 09000064818c02c3
FDA-1975-N-0012-0632 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 9 Volume 1 of 2 Gill, M.W., et al. Chronic Dietary Oncogenicity Study with ADBAC in Mice re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:17:20Z   0 0 09000064818c28cb
FDA-1975-N-0012-0627 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 6 Selim, Sami Absorption, Distribution, Metabolism and Excretion Studies of ADBAC in the Rat re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:15:32Z   0 0 09000064818c222d
FDA-1975-N-0012-0624 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 3 Neeper Bradley T.L. Developmental Toxicity Evaluation II of ADBAC Administered by Gavage to CD Rats re Comment from the ADBAC Steering Committee Lewis & Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:14:32Z   0 0 09000064818c1c56
FDA-1975-N-0012-0628 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 7 Neeper Bradley, Theresa L Two Generation Reproduction Study in Sprague Dawley Rats with ADBAC Administered in the Diet re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:15:50Z   0 0 09000064818c2427
FDA-1975-N-0012-0629 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 8 Volume 1 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:16:37Z   0 0 09000064818c25eb
FDA-1975-N-0012-0625 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 4 Gill, M.W. and Wagner C.L. Ninety Day Subchronic Dermal Toxicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis & Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:14:44Z   0 0 09000064818c20a2
FDA-1975-N-0012-0626 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 5 Goldenthal, Edwin I. Evaluation of ADBAC in a One Year Chronic Dietary Toxicity Study in Dogs re Comment from the ADBAC Steering Committee Lewis & Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:14:52Z   0 0 09000064818c2227
FDA-1975-N-0012-0631 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 8 Volume 3 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:17:06Z   0 0 09000064818c25f3
FDA-1975-N-0012-0623 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 2 Van Miller, J.P. and Weaver, E.V. Ninety Day Dietary Toxicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis & Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:14:21Z   0 0 09000064818c1c53
FDA-1975-N-0012-0633 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Study 9 Volume 2 of 2 Gill, M.W., et al. Chronic Dietary Oncogenicity Study with ADBAC in Mice re Comment from the ADBAC Steering Committee Lewis and Harrison Supporting & Related Material Background Material 2015-10-21T04:00:00Z 2015 10     2016-03-22T19:17:27Z   0 0 09000064818c28cd
FDA-1975-N-0012-0543 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Memorandum of Meeting Minutes Between FDA CDER and American Cleaning Institute on April 24, 2015 Other Memorandum 2015-07-07T04:00:00Z 2015 7 2015-07-07T04:00:00Z   2015-07-07T19:12:21Z   0 0 0900006481b6f792
FDA-1975-N-0012-0542 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from FDA CDER to American Cleaning Institute Other Letter(s) 2015-07-07T04:00:00Z 2015 7 2015-07-07T04:00:00Z   2015-07-07T19:12:15Z   0 0 0900006481b6f78f
FDA-1975-N-0012-0541 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Memorandum of Meeting Minutes Between FDA CDER and American Cleaning Institute Other Memorandum 2015-07-07T04:00:00Z 2015 7 2015-07-07T04:00:00Z   2015-07-07T19:11:58Z   0 0 0900006481b6f397
FDA-1975-N-0012-0537 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from Lonza, Inc. (Lewis and Harrison) Other Letter(s) 2015-05-20T04:00:00Z 2015 5 2015-05-20T04:00:00Z   2015-05-20T18:57:40Z   0 0 0900006481aec6de
FDA-1975-N-0012-0538 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Attachment 1 Draft Protocol for Uterotrophic re Letter from Lonza Inc Lewis and Harrison Supporting & Related Material Background Material 2015-05-20T04:00:00Z 2015 5     2015-05-20T20:21:30Z   0 0 0900006481aec0ee
FDA-1975-N-0012-0539 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Attachment 2 FDA-QSAR for Benzethonium Chloride and Alkyl Dimetylbenzylammonium Chloride re Letter from Lonza Inc Lewis and Harrison Supporting & Related Material Background Material 2015-05-20T04:00:00Z 2015 5     2015-05-20T20:21:37Z   0 0 0900006481aec0ef
FDA-1975-N-0012-0540 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Attachment 4 Draft Protocol for Hershberger Bioassay of Benzethonium Chloride USP by Oral in Male Rats re Letter from Lonza Inc Lewis and Harrison Supporting & Related Material Background Material 2015-05-20T04:00:00Z 2015 5     2015-05-20T20:21:46Z   0 0 0900006481aece32
FDA-1975-N-0012-0536 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from FDA CDER to Lonza America Inc. Granting Meeting Request regarding Potential Endocrine Effects of Benzethonium Chloride and Benzalkonium Chloride Other Letter(s) 2015-04-24T04:00:00Z 2015 4 2015-04-24T04:00:00Z   2015-04-24T19:44:06Z   0 0 0900006481ab9bdc
FDA-1975-N-0012-0535 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from FDA CDER to American Cleaning Institute Granting Meeting Request Regarding Chloroxylenol Other Letter(s) 2015-04-15T04:00:00Z 2015 4 2015-04-15T04:00:00Z   2015-04-16T14:07:15Z   0 0 0900006481aa7b59
FDA-1975-N-0012-0524 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Supplementary Material Weight of Evidence Framework for EDSP Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:30:33Z   0 0 0900006481a95398
FDA-1975-N-0012-0532 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix F: Assessment of the Percutaneous Absorption of Chloroxylenol, and Effects of Formulation Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T16:21:32Z   0 0 0900006481a970c6
FDA-1975-N-0012-0515 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 1 Coalition Melon Ball Disease Transmission Model Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2020-02-07T19:33:21Z   0 0 0900006481a95723
FDA-1975-N-0012-0518 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 4 Comments Submitted by the American Cleaning Institute and Personal Care Products Council on FDA Proposed Rule for Safety and Effectiveness of Consumer Antiseptics (78 FR 76444-76478; December 17, 2013), Appendix B Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:28:05Z   0 0 0900006481a95726
FDA-1975-N-0012-0529 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix C: Assessment of the Hormonal Effects Database for Chloroxylenol Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:59:59Z   0 0 0900006481a970c3
FDA-1975-N-0012-0531 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix E: Assessment of the Pharmacokinetics (ADME) Database for Chloroxylenol Summary of Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T16:15:31Z   0 0 0900006481a970c5
FDA-1975-N-0012-0516 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 2 Excerpts from Henkel Submission Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:27:13Z   0 0 0900006481a95724
FDA-1975-N-0012-0520 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 6 Comments Submitted by the American Cleaning Institute and Personal Care Products Council on FDA proposed rule for Safety and Effectiveness of Consumer Antiseptics (78 FR 76444-76478; December 17, 2013), Appendix C Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:29:14Z   0 0 0900006481a95728
FDA-1975-N-0012-0519 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 5 Schaffner, DW et al. 2014. Quantitative Microbial Risk Assessment of Antibacterial Hand Hygiene Products on the Risk of Shigellosis. Journal of Food Protection. 77(4): 574 - 582 Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2020-02-07T17:27:39Z   0 0 0900006481a95727
FDA-1975-N-0012-0521 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 7 Final Report Summary BIOHYPO (Confronting the clinical relevance of biocide induced antibiotic resistance) http://cordis.europa.eu/result/rcn/56830 en.html Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:29:33Z   0 0 0900006481a95729
FDA-1975-N-0012-0528 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix B: Assessment of the Developmental and Reproductive (DART) Database for Chloroxylenol Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:52:04Z   0 0 0900006481a970c2
FDA-1975-N-0012-0523 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 9 Borgert, C. J., Mihaich, E. M., Ortego, L. S., Bentley, K. S., Holmes, C. M., Levine, S. L. and Becker, R. A. 2011. Hypothesis-driven Weight of Evidence Framework for Evaluating Data within the US EPA's Endocrine Disruptor Screening Program. Regul Toxicol Pharmacal, 61: 185-91 Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:30:13Z   0 0 0900006481a95397
FDA-1975-N-0012-0527 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix A: Chloroxylenol Antimicrobial Efficacy and ResistanceRe: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:43:08Z   0 0 0900006481a970c1
FDA-1975-N-0012-0522 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 8 Oggioni. M.R., L. Furi, J.R. Coelho, J-Y. Maillard, J.L. Martinez. 2013. Recent Advances in the Potential Interconnection between Antimicrobial Resistance to Biocides and Antibiotics. Expert Rev Anti Infect Ther. 11(4):363-6 Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:29:52Z   0 0 0900006481a9572a
FDA-1975-N-0012-0525 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Briefing Document from American Cleaning Institute Other Brief 2015-04-09T04:00:00Z 2015 4 2015-04-09T04:00:00Z   2015-04-09T15:25:57Z   0 0 0900006481a970be
FDA-1975-N-0012-0526 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 1 Exponent FDA Consumer Antiseptics Rule: FDA Request for Data on Safety and Efficacy of ChloroxylenolRe: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:39:47Z   0 0 0900006481a970c0
FDA-1975-N-0012-0530 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix D: Assessment of the Mutagenic and Carcinogenic Effects for Chloroxylenol Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T16:06:07Z   0 0 0900006481a970c4
FDA-1975-N-0012-0517 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 3 Boyce, J.M et al. 2012. An Expert Panel Report of a Proposed Scientific Model Demonstrating the Effectiveness of Antibacterial Handwash Products. American Journal of Infection Control, 40: 742-9 Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T15:27:37Z   0 0 0900006481a95725
FDA-1975-N-0012-0534 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 APPENDIX 3 Sanderson H, Counts JL, Stanton KL, Sedlak Rl. 2006. Exposure and Prioritization-Human Screening Data and Methods for High Production Volume Chemicals in Consumer Products: Amine oxides, A Case Study Risk Analysis 26:1637-1657 Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T16:33:36Z   0 0 0900006481a9710b
FDA-1975-N-0012-0533 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Appendix 2 Risk Assessment of Chloroxylenol in Liquid Hand Soap Used by Consumers and Health-Care Providers Re: Briefing Document from American Cleaning Institute Supporting & Related Material Background Material 2015-04-09T04:00:00Z 2015 4     2015-04-09T16:27:58Z   0 0 0900006481a970c7
FDA-1975-N-0012-0514 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Briefing Document from American Cleaning Institute Other Brief 2015-04-08T04:00:00Z 2015 4 2015-04-08T04:00:00Z   2015-04-08T18:34:17Z   0 0 0900006481a95600
FDA-1975-N-0012-0513 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from FDA/CDER to Personal Care Products Council and American Cleaning Institute Granting Meeting Request Other Letter(s) 2015-03-09T04:00:00Z 2015 3 2015-03-09T04:00:00Z   2015-03-09T14:35:15Z   0 0 0900006481a33f3d
FDA-1975-N-0012-0512 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Interim Response Letter from FDA CDER to the American Cleaning Institute and Personal Care Products Council Other Letter(s) 2015-02-27T05:00:00Z 2015 2 2015-02-27T05:00:00Z   2015-05-20T18:41:10Z   0 0 0900006481a1e054
FDA-1975-N-0012-0511 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from the Personal Care Products Council and American Cleaning Institute to FDA/CDER re Letter from the Personal Care Products Council Covington and Burling LLP Supporting & Related Material Background Material 2015-01-07T05:00:00Z 2015 1     2015-01-07T22:09:32Z   0 0 09000064819ac234
FDA-1975-N-0012-0510 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Letter from the Personal Care Products Council Covington & Burling LLP Other Letter(s) 2015-01-07T05:00:00Z 2015 1 2015-01-07T05:00:00Z   2015-01-07T22:04:35Z   0 0 09000064819ac1ee

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 1747.408ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API